【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 10
2.1 What Is This Report About? 10
2.2 Disposable Hospital Supplies Market Segmentation 10
2.3 Definitions of Markets Covered in the Report 11
3 Disposable Hospital Supplies Market, North America 12
3.1 Disposable Hospital Supplies Market, North America, Revenue ($m), 2007-2021 12
3.2 Disposable Hospital Supplies Market, North America, Category Comparison by Revenue ($m), 2007-2021 14
3.3 Disposable Hospital Supplies Market, North America, Revenue ($m), 2007-2014 16
3.4 Disposable Hospital Supplies Market, North America, Revenue ($m), 2014-2021 18
3.5 Disposable Hospital Supplies Market, North America, Volume (Units), 2007-2021 20
3.6 Disposable Hospital Supplies Market, North America, Volume (Units), 2007-2014 21
3.7 Disposable Hospital Supplies Market, North America, Volume (Units), 2014-2021 23
3.8 Disposable Hospital Supplies Market, North America, Company Share by Revenue ($m), 2014 25
4 Disposable Hospital Supplies Market, Canada 27
4.1 Disposable Hospital Supplies Market, Canada, Revenue ($m), 2007-2014 27
4.2 Disposable Hospital Supplies Market, Canada, Revenue ($m), 2014-2021 29
4.3 Disposable Hospital Supplies Market, Canada, Volume (Units), 2007-2014 31
4.4 Disposable Hospital Supplies Market, Canada, Volume (Units), 2014-2021 33
4.5 Disposable Hospital Supplies Market, Canada, Average Price ($), 2007-2021 35
4.6 Disposable Hospital Supplies Market, Canada, Distribution Share by Revenue ($m), 2013-2014 37
4.7 Disposable Hospital Supplies Market, Canada, Company Share by Revenue ($m), 2014 38
5 Disposable Hospital Supplies Market, Mexico 40
5.1 Disposable Hospital Supplies Market, Mexico, Revenue ($m), 2007-2014 40
5.2 Disposable Hospital Supplies Market, Mexico, Revenue ($m), 2014-2021 42
5.3 Disposable Hospital Supplies Market, Mexico, Volume (Units), 2007-2014 44
5.4 Disposable Hospital Supplies Market, Mexico, Volume (Units), 2014-2021 46
5.5 Disposable Hospital Supplies Market, Mexico, Average Price ($), 2007-2021 48
5.6 Disposable Hospital Supplies Market, Mexico, Distribution Share by Revenue ($m), 2013-2014 50
5.7 Disposable Hospital Supplies Market, Mexico, Company Share by Revenue ($m), 2014 51
6 Disposable Hospital Supplies Market, United States 53
6.1 Disposable Hospital Supplies Market, United States, Revenue ($m), 2007-2014 53
6.2 Disposable Hospital Supplies Market, United States, Revenue ($m), 2014-2021 55
6.3 Disposable Hospital Supplies Market, United States, Volume (Units), 2007-2014 57
6.4 Disposable Hospital Supplies Market, United States, Volume (Units), 2014-2021 59
6.5 Disposable Hospital Supplies Market, United States, Average Price ($), 2007-2021 61
6.6 Disposable Hospital Supplies Market, United States, Distribution Share by Revenue ($m), 2013-2014 63
6.7 Disposable Hospital Supplies Market, United States, Company Share by Revenue ($m), 2014 64
7 Overview of Key Companies in North America Disposable Hospital Supplies Market 66
7.1 Cardinal Health, Inc. 66
7.1.1 Company Overview 66
7.2 Halyard Health, Inc. 66
7.2.1 Company Overview 66
7.3 Medline Industries, Inc. 66
7.3.1 Company Overview 66
7.4 3M Health Care Ltd. 67
7.4.1 Company Overview 67
7.5 Molnlycke Health Care AB 67
7.5.1 Company Overview 67
7.6 Covidien plc 67
7.6.1 Company Overview 67
8 Disposable Hospital Supplies Market Pipeline Products 68
9 Recent Developments 69
9.1 Corporate Communications 69
9.1.1 Mar 10, 2016: Cesca Therapeutics Appoints Dr. Xiaochun Xu, Chairman and CEO of Boyalife Group, to Board of Directors 69
9.1.2 Jan 13, 2016: Command Medical Products Hires John Walter as Director of New Business Development 69
9.1.3 Nov 20, 2015: Marc Gibeley Joins Board of Directors of Invacare 70
9.1.4 Oct 28, 2015: SteadyMed Announces Positive Clinical Study Results in Support of SMT-201 for the Treatment of Post Surgical Pain in the Home Setting 70
9.1.5 Oct 28, 2015: Baxter Names José Almeida Chairman and CEO 72
9.1.6 Oct 27, 2015: Baxter To Reduce Workforce 72
9.1.7 Oct 26, 2015: Michael Bruch Appointed Chief Financial Officer of Cesca Therapeutics 72
9.1.8 Oct 21, 2015: Baxter Appoints Michael F. Mahoney to Its Board 73
9.1.9 Oct 15, 2015: Actinium Announces Completion of the Fourth and Final Cohort of Its Actimab-A Trial 73
9.1.10 Sep 30, 2015: Baxter Appoints Munib Islam to Board; Announces Agreement with Third Point 74
9.1.11 Sep 29, 2015: Anacor Pharmaceuticals Announces Presentations of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data at Two Upcoming Medical Conferences 75
9.1.12 Sep 28, 2015: Ken Harris to Step Down as President of Cesca Therapeutics 75
9.1.13 Sep 15, 2015: Cesca Therapeutics Announces Restructuring Initiative 76
9.1.14 Sep 11, 2015: Owens & Minor Names W. Marshall Simpson as Executive Vice President & Chief Commercial Officer 76
9.1.15 Aug 27, 2015: Spectranetics Names Stacy McMahan Chief Financial Officer 77
9.1.16 Jul 09, 2015: SonaCare Medical Sells Prostate Ablation System with MRI/Ultrasound Image Fusion to Heidelberg Prostate Clinic 77
9.1.17 Jun 19, 2015: Mal Mixon to Retire from Invacare Board of Directors 78
9.1.18 Jun 12, 2015: Cesca Therapeutics Board of Directors Appoint Robin C. Stracey as Chief Executive Officer 78
9.1.19 May 20, 2015: Owens & Minor Names P. Cody Phipps President & Chief Executive Officer, Effective July 1 79
9.1.20 May 14, 2015: Bellicum Announces Clinical Study Results Published in BLOOD and Featured in Late-Breaking Session at ASGCT Annual Meeting 80
9.1.21 May 14, 2015: Invacare Adds Two New Board Members 81
9.1.22 May 04, 2015: Cesca Therapeutics Announces Changes in Management 82
9.1.23 Apr 30, 2015: Integra LifeSciences Names Keith Valentine as Chief Executive Officer of SeaSpine; John Bostjancic Appointed as Chief Financial Officer of SeaSpine 82
9.2 Financial Announcements 83
9.2.1 Feb 25, 2016: Integra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance 83
9.2.2 Feb 16, 2016: Cesca Therapeutics Reports Second Quarter Fiscal 2016 Results and Provides a Status Update to Investors 85
9.2.3 Feb 11, 2016: Invacare Announces Financial Results for the Quarter and Year Ended December 31, 2015 86
9.2.4 Feb 08, 2016: Owens & Minor Reports 4th Quarter & Full-Year 2015 Financial Results 93
9.2.5 Feb 02, 2016: Baxter Announces Fourth Quarter Results and Provides 2016 Financial Outlook 94
9.2.6 Feb 01, 2016: Hill-Rom Reports Strong First Quarter Results Exceeding Previous Guidance and Increases Full Year Earnings Outlook 96
9.2.7 Jan 27, 2016: Sharps Compliance Reports Record Customer Billings of $10.5 Million for the Second Quarter of Fiscal 2016 97
9.2.8 Jan 12, 2016: Hill-Rom Reports Preliminary Fiscal First Quarter Revenue 100
9.2.9 Dec 07, 2015: Leading HIFU Expert Begins U.S.-Based Program With Treatment Of First Prostate Cancer Patients 101
9.2.10 Nov 25, 2015: Pall Reports First Quarter Results 103
9.2.11 Nov 23, 2015: AdvanSource Biomaterials Reports Fiscal 2016 Second Quarter Results and Third Consecutive Quarterly Profit 103
9.2.12 Nov 16, 2015: Vigilant Biosciences Receives CE Mark for OncAlertTM Oral Cancer CD44/Total Protein LAB Test to Aid in Diagnosis of Oral Cancer 104
9.2.13 Nov 16, 2015: Leviticus Cardio Achieves Successful Transcutaneous Coplanar Energy Transfer in Chronic Animal Model 106
9.2.14 Nov 16, 2015: Cesca Therapeutics Reports First Quarter Fiscal Year 2016 Financial Results 107
9.2.15 Nov 15, 2015: ERBA to Launch LISA XL System in Europe and International Markets; Product to be Featured at MEDICA 2015 109
9.2.16 Nov 13, 2015: Lumenis Expands Its Portfolio of Gynecology Solutions with the New UltraPulse DUO for Fertility-Related Disorders and FemTouch for Improved Vaginal Health 111
9.2.17 Nov 12, 2015: In New Study EMMA Capnograph Has Comparable Accuracy to Sidestream Capnography Against Gold-Standard Blood Gas Analysis 113
9.2.18 Nov 05, 2015: Hill-Rom Reports Strong Fourth Quarter and Full-Year Results Exceeding Previous Guidance 114
9.2.19 Nov 03, 2015: Integra LifeSciences Reports Third Quarter 2015 Financial Results 116
9.2.20 Oct 30, 2015: Licensee’s drug to commence Phase 2 and Phase 3 trials 117
9.2.21 Oct 29, 2015: Neuren Completes Enrolment in “INTREPID” Clinical Trial 118
9.2.22 Oct 28, 2015: New Study Bolsters Cologuard’s Performance in Detecting Colorectal Cancer and Ability to Improve Access to Screening 119
9.2.23 Oct 28, 2015: Sharps Compliance Fiscal 2016 First Quarter Revenue Increases 12% to $7.9 Million 120
9.2.24 Oct 27, 2015: Baxter Reports Strong Third Quarter Financial Results Exceeding Previously Issued Guidance 122
9.2.25 Oct 27, 2015: Owens & Minor Releases 3rd Quarter 2015 Financial Results 123
9.2.26 Oct 22, 2015: Spectranetics Achieves Third Quarter 2015 Revenue of $61.7 Million 125
9.2.27 Oct 22, 2015: Invacare Announces Financial Results for the Third Quarter and Nine Months of 2015 126
9.2.28 Oct 15, 2015: ConvaTec: Third Quarter 2015 Report 130
9.2.29 Oct 08, 2015: Allergan To Present Data On Anti-Infective Drug AVYCAZ at IDWeek 2015 134
9.2.30 Sep 30, 2015: Zogenix Reports Positive Top-Line Results From Relday Phase 1b Multi-Dose Clinical Trial 135
9.2.31 Sep 29, 2015: Motif Announces Presentation of Two Posters on Iclaprim at ID Week 2015 138
9.2.32 Sep 17, 2015: Zealand advances its proprietary, long-acting GLP-2 analogue, ZP1848, into clinical Phase II development for the treatment of Short Bowel Syndrome 139
9.2.33 Sep 17, 2015: Cesca Therapeutics Reports Fiscal Year 2015 Results 142
9.2.34 Aug 27, 2015: RedHill Biopharma Receives Notice of Allowance for New Israeli Patent Covering RHB-104 for the Treatment of Crohn’s Disease 143
9.2.35 Aug 20, 2015: AdvanSource Biomaterials Reports Fiscal 2016 First Quarter Results and Second Consecutive Quarterly Profit 145
9.2.36 Aug 12, 2015: Sharps Compliance Fiscal 2015 Fourth Quarter Revenue Increases 27% To $9.0 Million; Customer Billings Increase 28% to $9.4 Million 146
9.2.37 Aug 11, 2015: Command Medical Products Announces Promotion to Vice President 149
9.2.38 Aug 07, 2015: Hill-Rom Reports Strong Third Quarter Results; Updates 2015 Adjusted Earnings Outlook 149
9.2.39 Aug 04, 2015: Alpha Pro Tech Announces Financial Results For The 2015 Second Quarter 151
9.2.40 Jul 30, 2015: Integra LifeSciences Reports Second Quarter 2015 Financial Results 153
9.2.41 Jul 29, 2015: Baxter Reports Strong Second Quarter Financial Results Exceeding Guidance 154
9.2.42 Jul 29, 2015: Hospira Reports Second-Quarter 2015 Results 156
9.2.43 Jul 27, 2015: Owens & Minor Releases 2nd Quarter 2015 Financial Results 157
9.2.44 Jul 23, 2015: Invacare Announces Financial Results for the Second Quarter and First Six Months of 2015 159
9.2.45 Jul 23, 2015: Spectranetics Reports Second Quarter Financial Results 163
9.2.46 Jul 15, 2015: Newest FDA-Cleared Breakthrough In Women’s Health Treatments Provided at the Healthcare Practice of Lizellen La Follette, MD 163
9.2.47 Jul 15, 2015: ConvaTec: Second Quarter 2015 Report 165
9.2.48 Jul 14, 2015: NorthShore University HealthSystem Becomes First in Illinois to Install Revolutionary Neurological Operating System 168
9.2.49 Jul 13, 2015: Study Demonstrates Accuracy of GlySure Continuous Intravascular Glucose Monitoring System in Critically Ill Patients 170
9.2.50 Jun 23, 2015: Cesca Therapeutics Reports Third Quarter Fiscal 2015 Results 172
9.2.51 May 21, 2015: Pall Reports Third Quarter Results 173
9.2.52 May 06, 2015: Alpha Pro Tech Announces Financial Results For The 2015 First Quarter 174
9.2.53 May 05, 2015: Hill-Rom Reports Second Quarter Results Ahead Of Guidance; Increases 2015 Adjusted Earnings Outlook 175
9.2.54 Apr 30, 2015: Integra LifeSciences Reports First Quarter 2015 Financial Results 176
9.2.55 Apr 28, 2015: Hospira Reports First-Quarter 2015 Results 178
9.2.56 Apr 27, 2015: Medtronic Announces Consent Decree with FDA for the Synchromed Drug Infusion System 179
9.2.57 Apr 27, 2015: Owens & Minor Reports 1st Quarter 2015 Financial Results 181
9.2.58 Apr 23, 2015: Spectranetics Achieves First Quarter 2015 Revenue of $57.4 Million 182
9.2.59 Apr 23, 2015: Invacare Announces Financial Results for the First Quarter of 2015 182
9.2.60 Apr 23, 2015: Baxter Reports First Quarter Financial Results That Exceed Guidance 185
9.2.61 Apr 16, 2015: Arch Therapeutics’ AC5 Compared Favorably vs. Commercially Available Combination Hemostat in Animal Study 187
9.2.62 Apr 15, 2015: ConvaTec: First Quarter 2015 Report 188
9.2.63 Apr 07, 2015: Positive Clinical Data for iCAD’s Xoft System to be Highlighted at American Brachytherapy Society Annual Meeting 190
9.2.64 Mar 30, 2015: BRILINTA receives US FDA approval for new administration option 192
9.3 Government and Public Interest 194
9.3.1 Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean 194
9.4 Legal And Regulatory 196
9.4.1 May 01, 2015: Hospira Statement On FDA’s Final Biosimilar Guidance Documents 196
9.4.2 Apr 17, 2015: Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant 197
9.4.3 Apr 13, 2015: Hope for Greater Access for Patients to Biosimilar Medicines 197
9.5 Other Significant Developments 198
9.5.1 Mar 11, 2016: Alzheon Announces Efficacy Analyses of Prior Tramiprosate Phase 3 Studies Showing Clinically Meaningful Benefits on Key Clinical Endpoints in Alzheimer’s Disease Patients with APOE4 Genotype 198
9.5.2 Feb 22, 2016: Sysmex America Signs Distributor Agreement With Medline 199
9.5.3 Jan 06, 2016: FONAR Management Subsidiary HMCA Adds 25th MRI Center 200
9.5.4 Dec 28, 2015: Tennessee Health Management Selects Medline as Exclusive Distribution Partner in $4 Million Prime Vendor Deal 200
9.5.5 Dec 07, 2015: ARxIUM Selects Additional Distributors of RIVA Automated Compounding System for Asia-Pacific Region 201
9.5.6 Nov 17, 2015: Medline to Provide Robust Product Portfolio and Strategic Tools to More Than 200 Physician Offices Through New $9 Million Prime Vendor Agreement 202
9.5.7 Oct 20, 2015: ARxIUM Selects Silver Wing Asia-Pacific International Medical Technology Company as its Exclusive Distributor of RIVA Automated Compounding System in Mainland China 202
9.5.8 Sep 28, 2015: Esperion Therapeutics Provides Further Updates on ETC-1002 Global Phase 3 Strategy Following Receipt of End-of-Phase 2 Meeting Minutes 203
9.5.9 Sep 15, 2015: Medline Secures Exclusive Distribution Partnership with OSF HealthCare in $250 Million Prime Vendor Deal 204
9.5.10 Sep 11, 2015: Pall Ilfracombe, UK Manufacturing Facility Wins Gold at the 2015 RoSPA Occupational Health and Safety Awards 204
9.5.11 Aug 25, 2015: Jhpiego and Johns Hopkins Center for Bioengineering Innovation & Design Selected as Finalist for 2015 INDEX: Award 205
9.5.12 Mar 30, 2015: Baxter Expands Access to Healthcare Through Collaborations and Charitable Giving 205
9.5.13 Mar 26, 2015: Medline to Provide American Academy of Orthopaedic Surgeons Members Significant Cost-Savings, Clinical and Quality Assurance Solutions through New Preferred Supplier Agreement 207
9.6 Product News 208
9.6.1 Jan 26, 2016: Baxter initiates Voluntary Nationwide Recall of Select Lots of IV Solutions Due to the Potential for Leaking Containers and Particulate Matter 208
9.7 Strategy And Business Planning 209
9.7.1 Mar 02, 2016: First patient dosed in iclaprim Phase 3 trials to treat skin infections 209
9.7.2 Jan 14, 2016: Scrutiny of Essure Increases as Women Come Forward Claiming Permanent Injuries 209
9.7.3 Nov 12, 2015: Baxter Completes Capacity Expansion at Halle, Germany Facility to Support BioPharma Solutions’ Oncology Contract Manufacturing Services 211
9.7.4 Oct 15, 2015: Baxter International expanding operations in Mountain Home 212
9.7.5 Sep 28, 2015: Clinical Data Presented On Binimetinib And Encorafenib In Melanoma 212
9.7.6 Jul 07, 2015: PrenaTest is now reimbursed by Swiss statutory health insurance programs 215
9.7.7 Jul 01, 2015: Integra LifeSciences Completes Spin-Off of SeaSpine 215
9.7.8 May 18, 2015: Baxter and Baxalta Highlight Business Strategies at Investor Conference 216
9.7.9 Apr 01, 2015: Integra LifeSciences Announces the Filing of the Form 10 Registration Statement for the Planned Spin-off of the Orthobiologics and Spinal Fusion Hardware Business, SeaSpine 218
10 Appendix 219
10.1 Research Methodology 220
10.1.1 Coverage 220
10.1.2 Secondary Research 220
10.1.3 Primary Research 220
10.1.4 Company Share Analysis 221
10.1.5 Distribution Share Analysis 221
10.2 GlobalData Consulting 221
10.3 Contact Us 221
10.4 Disclaimer 222
【レポート販売概要】
■ タイトル：北米の使い捨て病院用品市場見通し（～2021）■ 英文：North America Disposable Hospital Supplies Market Outlook to 2021
■ 発行日：2016年4月1日
■ 調査会社：GlobalData
■ 商品コード：GDMECR0425DB
■ 調査対象地域：北米
- 世界のガソリン添加剤市場2015The Global Gasoline Additives Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Gasoline Additives industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Gasoline Additives market analysis is provided for the international markets including development t …
- 世界のプロパン酸及びプロパン酸誘導体市場Propionic acid is a three-carbon carboxylic acid with a molecular formula of CH3CH2COOH. It is a clear, colorless liquid with a pungent odor. It is commercially manufactured by the hydrocarboxylation of ethylene in the presence of nickel carbonyl catalyst. Propionic acid and derivatives are largely used as feed and food preservatives. It inhibits the growth of molds and bacteria. Propionic acid is …
- 3Dプリンティング市場：技術、市場予測、事業機会3D printing technology has a broad range of applications, including consumer products, medical equipment, machine parts, automobile components, architecture models, toys, and even food and dessert. This report profiles major 3D printing processes, such as SLA, SLS, LOM, and FDM, to name a few, with their pros and cons analyzed. Also included are the 3D printer market value forecast and market oppo …
- グローバル軍事衛星市場（2014-2024）：動向、開発、課題Synopsis This report offers readers insights into technological developments in the Military Satellite market, as well as detailed analysis of the changing preferences of military forces around the world. It also identifies the current trends in the changing industry structure and the challenges faced by industry participants. Summary Technological Developments in the global Military Satellite inc …
- 爪真菌症(爪白癬)(Onychomycosis (Tinea Unguium))の治療薬パイプライン動向（2015年上半期版）Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2015’, provides an overview of the Onychomycosis (Tinea Unguium)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Onychomycosis (Tinea Unguium), complete with comparative analysis at various stages, t …
- 食品産業向けメンブレンの世界市場2015-2019About Membranes in Food Industry Membranes are a type of selective barrier used for separation or concentration of feed stream. A membrane allows some constituents of the feed stream to pass through and others are retained on the surface of the membrane. The constituents of the feed stream that are allowed to pass through the membrane are known as permeates and that are retained back are known as …
- マーケティング自動化ソフトウェアの世界市場：キャンペーン管理、Eメールマーケティング、モバイルアプリ、ソーシャルメディアマーケティング等The marketing automation software is a sales and marketing tool that helps the company to nurture leads with their likes and dislikes and turn the customers into delighted customers. The software understands the leads behaviour and on that behaviour do scoring and converting into quality leads to the sales team. The software broadly focuses on range of automation and analytic tool for sales and ma …
- 世界のシェールガス産業における主要企業分析The extraction of oil and gas from shale formations is a relatively new phenomenon with commercial production only first occurring in the twenty-first century. Shale rock formations have low permeability and porosity and so require the use of horizontal drilling and hydraulic fracturing in order to extract the hydrocarbon resources. The techniques to develop hydrocarbons from shale formations was …
- 世界の自動車用ブレーキシステム市場Automotive brakes have evolved from simple wooden block brakes which were used in steel rimmed wheels, to the modern day disc and drum brakes with electronic assistance. The key function of brakes in automobiles is to slow down or stop the vehicle in motion. A majority of the brakes used in automobiles are of friction types, in which the brakes use friction to slow down the vehicle. In this, brake …
- (E,E,E,E)-スクアレンの世界市場(E,E,E,E)-Squalene (CAS 111-02-4) Market Research Report 2013 presents comprehensive data on (E,E,E,E)-squalene markets globally and regionally (Europe, Asia, North America etc.) The (E,E,E,E)-Squalene (CAS 111-02-4) Market Research Report 2013 includes (E,E,E,E)-squalene description, covers its application areas and related patterns. It overviews (E,E,E,E)-squalene market, names (E,E,E,E)-squalen …
- 自動車補修塗料の世界市場分析：樹脂タイプ別（アクリル、アルキド、ポリウレタン）、技術別（水系、溶剤系、UV硬化型）、製品別（プライマー、ベースコート、フィラー、トップコート）、車の年数別（5年未満、5～10年、10年以上）、セグメント予測The global automotive refinish coatings market is expected to reach USD 14.88 billion by 2024, according to a new report by Grand View Research, Inc. Rising demand for automotive refinish coatings as they improve the durability and enhance the appearance of vehicles will fuel market growth over the next eight years. Furthermore, aging of vehicles, rising demand for repair, maintenance, and afterma …
- スマートポリマーの世界市場予測（～2022年）The smart polymers market was USD 634.2 Million in 2016 and projected to reach USD 2,071.1 Million by 2022, at a CAGR of 21.9% between 2017 and 2022. Increasing adoption of smart polymers in the automotive and drug delivery sectors, development of smart textiles, and rising need for efficient drug delivery systems is expected to drive the global smart polymers market during the forecast period. Sm …
- 季節性アレルギー性鼻炎(Seasonal Allergic Rhinitis)の治療薬パイプライン動向（2015年上半期版）Seasonal Allergic Rhinitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Seasonal Allergic Rhinitis - Pipeline Review, H1 2015’, provides an overview of the Seasonal Allergic Rhinitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Seasonal Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics …
- ベーカリー食品加工機械の世界市場：ミキサー、オーブン&プルーファー、ディバイダー、シーター&モルダーThe bakery processing equipment market is projected to grow at a CAGR of 7.3% from 2015 to 2020, to reach USD 13.62 Billion by 2020. The market growth is driven by an increased demand for bread, pastries, and other baked goods, growing demands for frozen bakery products, and advancement in manufacturing processes & technologies. The market is further driven by factors such as automation & robotics …
- 中小企業向け金融の世界市場2015-2019Micro, small and medium enterprises (MSME) are one of the key economic segments that drives the growth of the GDP by boosting the manufacturing and exports of the economy. The adoption of improved risk management practices by the financial institutions is one of the key drivers for the growth of this market. Technavio’s research analyst predicts the MSME financing market to grow at a rate of 19% d …
